High-dose cyclophosphamide in patients with operable breast cancer: recombinant human GM-CSF ameliorates drug-induced leukopenia and thrombocytopenia
Articolo
Data di Pubblicazione:
1990
Citazione:
High-dose cyclophosphamide in patients with operable breast cancer: recombinant human GM-CSF ameliorates drug-induced leukopenia and thrombocytopenia / M. Bregni, S. Siena, F. Ravagnani, G. Bonadonna, A. Gianni. - In: HAEMATOLOGICA. - ISSN 0390-6078. - 75 Suppl 1:1(1990), pp. 95-8-98.
Abstract:
Seventeen patients with breast cancer (nine patients with 10 ipsilateral metastatic axillary nodes, eight patients with inflammatory breast carcinoma) previously untreated with cytotoxic chemotherapy received high-dose cyclophosphamide, 7 g/sqm (HD-CTX) as initial step of a high-dose sequential chemotherapy program. Eleven patients received also intravenous recombinant human granulocyte macrophage-colony stimulating factor (GM-CSF), 5.5 micrograms/kg per day for 7-14 days after HD-CTX. This growth factor significantly ameliorated leukopenia and thrombocytopenia induced by HD-CTX therapy thus allowing earlier delivery of subsequent courses of chemotherapy.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Thrombocytopenia; Recombinant Proteins; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Growth Substances; Colony-Stimulating Factors; Adult; Breast Neoplasms; Middle Aged; Cyclophosphamide; Leukopenia; Female
Elenco autori:
M. Bregni, S. Siena, F. Ravagnani, G. Bonadonna, A. Gianni
Link alla scheda completa: